HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arden Net Sales Advance 7% In Q2 On Prevage, Fantasy Launches

This article was originally published in The Rose Sheet

Executive Summary

Elizabeth Arden will emphasize Internet banner and print advertising in support of its Prevage anti-aging product, while stepping back from mediums like outdoor advertising, CEO Scott Beattie said during a Feb. 2 second quarter earnings call

You may also be interested in...



Sales & Earnings In Brief

Revlon First Quarter: North American revenues were $216 mil. in Q1, representing an 11.3% gain from the prior year, Revlon reports during May 4 analyst call. Growth was driven largely by the launch of Vital Radiance and a re-stage of Almay products, company says. Net sales for the period grew 8.2% to $325.5 mil. Revlon experienced an operating loss of $17.2 mil. due to charges related to realignment expenses and shipments of Vital Radiance and Almay. Q1 net loss was $58.2 mil., compared with $46.8 mil. in the prior year quarter...

Sales & Earnings In Brief

Revlon First Quarter: North American revenues were $216 mil. in Q1, representing an 11.3% gain from the prior year, Revlon reports during May 4 analyst call. Growth was driven largely by the launch of Vital Radiance and a re-stage of Almay products, company says. Net sales for the period grew 8.2% to $325.5 mil. Revlon experienced an operating loss of $17.2 mil. due to charges related to realignment expenses and shipments of Vital Radiance and Almay. Q1 net loss was $58.2 mil., compared with $46.8 mil. in the prior year quarter...

Elizabeth Arden Unveils Premium-Priced Prevage Anti-Aging Treatment

Elizabeth Arden is positioning its Prevage Anti-Aging Treatment as a revolutionary formula that "alters the chain reaction that can result in older looking skin," according to the firm

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013680

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel